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ABSTRACT
OBJECTIVE
Elderly patients are legally as-
sumed to be competent to give 
consent to medical treatment. 
When patients are unable to 
make a decision on assenting or 
refusing treatment; if they cannot 
understand and remember the in-
formation provided, and⁄or cannot 
use that information when consid-
ering their decision, the deci-
sion-making capacity of the pa-
tient should be evaluated with 
specific clinical tools, since con-
sent obtained from an incompe-
tent patient is invalid. The clinical 
tool should be simple and easy to 
use, be replicable, and should re-
quire a short administration time 
and, possibly, no formal training. 
MATERIALS  
AND METHODS
We have considered frequently 
used clinical screening methods 
for cognitive impairment, such as 
the MacArthur Competence As-
sessment Tool for Treatment (Mac-
CAT-T), the Aid to Capacity Evalua-
tion (ACE) and the Mini Mental 
State Examination (MMSE), to 
evaluate the decision-making ca-
pacity of the patient. 
RESULTS
The MMSE is a very simple bed-
side clinical tool, does not re-
quire specific training, takes less 
than 10 minutes to complete, is 
objective and uses scores indi-
cating decreasing cognitive 
RIASSUNTO
OBIETTIVI
La capacità di un paziente anziano 
di prendere delle decisioni mediche 
deve essere considerata sempre 
valida, indipendentemente dall’età. 
Quando il paziente, però, non è in 
grado di accettare o rifiutare un 
trattamento, non può comprendere 
e ricordare le informazioni ricevute 
e/o non può utilizzare tali informa-
zioni quando deve esprimere la 
propria decisione, è necessario va-
lutare la sua capacità decisionale 
mediante strumenti clinici obiettivi, 
poiché il consenso ottenuto da un 
paziente privo di capacità decisio-
nale non è legalmente valido. Lo 
strumento per la valutazione della 
capacità decisionale dovrebbe es-
sere semplice e di facile uso, obiet-
tivo e replicabile; dovrebbe poter 
essere somministrato in breve tem-
po e, possibilmente, non richiedere 
alcun addestramento formale.
MATERIALI E METODI
Nel presente lavoro sono stati presi 
in considerazione i metodi di scree- 
ning più frequentemente utilizzati 
per valutare la capacità decisionale 
del paziente: il MacArthur Compe-
tence Assessment Tool for Tre-
atment (MacCAT-T), l’Aid to Capa-
city Evaluation (ACE) e il Mini Men-
tal State Examination (MMSE).
RISULTATI
Il MMSE è uno strumento clinico di 
semplice utilizzo, non richiede una 
formazione specifica, può essere 
somministrato in meno di 10 minuti, 
© 2018 EDRA SpA. Tutti i diritti riservati2018;86(7):612-619
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1. INTRODUCTION 
Obtaining informed consent is a corner-
stone of the practice of medicine, and 
every physician is legally and ethically 
obliged to seek consent from a patient 
before medical interventions. 
The informed consent is the process by 
which patients agree to a medical proce-
dure or treatment with regard to their 
health care. The process includes an ap-
propriate discussion between the clini-
cian and the patient, and covers all rele-
vant aspects of the proposed treatment. 
Consent is valid if it is given voluntarily, 
by an appropriately informed and com-
petent patient. 
Appelbaum and Grisso defined deci-
sion-making capacity as the ability to un-
derstand relevant information and to ap-
preciate the consequences of such a de-
cision[1]. In order to consent to a medical 
procedure, a patient must:
 - receive accurate, meaningful, and rele-
vant information regarding the nature 
and purpose of the treatment, as well 
as the risks, benefits, and alternatives 
to the proposed therapy, including no 
treatment (informed element);
 - be free from coercion (voluntary ele-
ment);
 - have medical decision-making capaci-
ty (competence element), that is the 
capacity to understand and communi-
cate, the capacity to reason and deli-
berate, and the possession of a set of 
values and goals[2].
In the process of obtaining the informed 
consent, it is critical to assess the pa-
tient’s decision-making capacity in order 
to determine his/her ability to provide the 
consent. In the geriatric population, the 
most rapidly growing segment of the Eu-
ropean population, assessing compe-
tence/capacity (competence is a term 
widely adopted in American legal writing 
and corresponds to the term mental ca-
pacity in British legal writing; in the text, 
they are used interchangeably) can be a 
complex task, and the physician needs 
to understand whether the patient is able 
to take a medical decision and give the 
consent. 
Every adult patient is legally assumed to 
be competent, however, in the clinical 
practice, failure to detect incompetence 
is quite common[3,4]. Where any doubt ex-
ists, the capacity of the patient to give 
medical consent should be assessed us-
ing specific tools appropriate to assess 
decision-making capacity. 
Concerning the medical/surgical/anaes-
thesia consent, the evaluation should be 
made by the physician responsible for 
the treatment. Consultation with psychia-
trists, geriatricians and ethicists should 
be indispensable only in very complex 
cases or when mental illness is present, 
and participation in the decision taking 
process constitutes a burden. 
In this article we will discuss the most ap-
propriate and, possibly, the easiest way 
to assess patient’s decision-making ca-
pacity especially in the elderly popula-
tion.
function. The scores range from 
0 to 30: a MMSE score of 0 to 17 
increases the likelihood of lack of 
capacity, a score of 18 to 23 in-
dicates mild cognitive impair-
ment, while a score of 24 to 30 
significantly reduces the likeli-
hood of incapacity. 
CONCLUSIONS
The Mini Mental State Examina-
tion can be considered the clinical 
tool more suitable for the physi-
cian in the daily practice. In pa-
tients with a low MMSE score, 
suggesting likelihood of lack of 
capacity, it will be necessary that 
the consent to medical proce-
dures be granted by a surrogate 
decision maker, according to the 
laws and jurisdiction of the coun-
try involved.
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è un test obiettivo e, anche se non è 
stato creato specificamente per va-
lutare l’incapacità, utilizza punteggi 
facilmente fruibili dal medico. Il pun-
teggio va da 0 a 30: un punteggio 
MMSE da 0 a 17 si associa a eleva-
ta probabilità di incapacità decisio-
nale; un punteggio da 18 a 23 indica 
un lieve deficit cognitivo, mentre il 
punteggio da 24 a 30 riduce signifi-
cativamente la probabilità di perdita 
dell’autonomia decisionale.
CONCLUSIONI
Il Mini Mental State Examination può 
essere considerato lo strumento cli-
nico più adatto per il medico nella 
pratica quotidiana. Nei pazienti con 
un basso punteggio MMSE, che 
suggerisce la probabilità di mancan-
za di capacità decisionale, sarà ne-
cessario che il consenso alle proce-
dure mediche sia concesso da un 
tutore legale o dall’amministratore di 
sostegno, secondo le leggi e la giuri-
sdizione del paese coinvolto.
PAROLE CHIAVE
 Paziente anziano
 Capacità decisionale
  Aid to Capacity Evaluation (ACE)
  MacArthur Competence 
Assessment Tool for Treatment 
(MacCAT-T)
  Mini Mental State Examination 
(MMSE)
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The assessment of decision-making ca-
pacity should be performed during the 
preoperative visit examination, and very 
often does not require specific evalua-
tion[4], provided that clinicians have im-
plemented effective strategies to im-
prove communication in the elderly. 
Assessing decision-making 
capacity
There are no formal guidelines from scien-
tific societies for the assessment of ca-
pacity to consent to treatment[12], although 
wide variety of criteria for assessing com-
petency have been suggested and inves-
tigated in the literature[4,13]. To reliable iden-
tify capacity impairment, the assessment 
should integrate three components: infor-
mation acquired from observing and talk-
ing to the patient; information acquired 
from talking with caregivers; information 
from the results of standardised tests. 
How to manage the discussion 
with the elderly patient 
and caregivers
During the visit, the elderly patient is in an 
unfamiliar environment, and very often 
the underlying disease can lead to confu-
sion and agitation. To improve the pa-
tient’s perception, the visit should be per-
formed in a room with adequate lightning 
and minimal distracting stimuli. It is nec-
essary to emphasize that, in order to 
evaluate decision-making capacity, all re-
versible causes of incapacity should be 
removed, and correction of presumed 
sensory deficits should be made. Since 
understanding is a key step in the cogni-
tive process leading to decision, every ef-
fort should be made to let the senior pa-
tient understand the medical information. 
Patients should be reminded to using 
their assistive devices (hearing aids, 
glasses, dentures) during the visit[14].
2. MATERIALS 
AND METHODS
We have consulted PubMed (Medline), 
Google Scholar, and the Cochrane data-
bases in search for original articles de-
scribing screening methods for the as-
sessment of cognitive impairment in el-
derly patients.
Existing literature reviews on the topic 
were also considered as additional infor-
mation. For this narrative review, we have 
considered the most frequently used 
clinical tools to evaluate the deci-
sion-making capacity of the patient, such 
as the MacArthur Competence Assess-
ment Tool for Treatment (MacCAT-T), the 
Aid to Capacity Evaluation (ACE) and the 
Mini Mental State Examination (MMSE). 
Informed consent in the elderly
Informed consent in elderly patients pre-
sents many ethical and legal challeng-
es[5]. The aging population is at risk of 
having cognitive impairment and there-
fore impaired decisional capacity. Cogni-
tive ageing is difficult to define, hard to 
measure, and impossible to predict; 
however, diminished understanding of in-
formation in patients with older age is fre-
quent and widely reported in the litera-
ture[6]. Before disclosure of information, 
the patient should be assessed for his/
her ability to understand the information, 
and communicate his/her wishes to the 
physician. 
In the majority of the cases, elderly pa-
tients are able to reach reasonable 
risk-taking decision to the same degree 
than young adults[7].
Many patients, however, may have no 
longer decision-making capacity be-
cause of learning disabilities, depression, 
brain injury and other forms of dementing 
illnesses affecting cognition[3].
Sessums et al. performed a meta-analy-
sis evaluating instruments to assess 
medical decision-making capacity for 
treatment choices, and found that less 
than 3% of healthy older adults lacked 
decision-making capacity, compared 
with 20% of persons with mild cognitive 
impairment and 54% of persons with 
Alzheimer disease[4].
Capacity is influenced by a variety of fac-
tors, including situational, psychosocial, 
medical, psychiatric, and neurological 
factors[8]. Lower educational level and 
physical illness strengthen the link be-
tween increasing age and impaired deci-
sion-making capacity[9]. Some patients 
lack capacity for specific periods of time, 
such as when critically ill, but not perma-
nently. Decision-making capacity may be 
mostly compromised by incipient de-
mentia; patients with amnestic mild cog-
nitive impairment and patients with 
Alzheimer’s disease have high rates of in-
competence with regard to such a deci-
sions[4,10,11].
THE USE OF STRUCTURED 
APPROACHES TO ASSESS  
THE ABILITIES IN ELDERLY  
PEOPLE CAN BE VERY  
HELPFUL FOR THE CLINICIAN
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When reversible problems interfere with 
the informed consent process, physi-
cians are ethically obliged to try to re-
verse or mitigate these factors. Obsta-
cles, such as pain, undue anxiety, and 
language barriers should be relieved. 
When fear or anxiety appear to interfere 
with ability to process the information 
during the visit, the presence of a known 
and trusted confidant or adviser (e.g., 
family member, caregiver) may improve 
the patient’s decision-making capacity. 
There might be communication difficul-
ties, due to level of education, hearing or 
visual impairment (that affect communi-
cation even when cognition is intact), or 
expressive aphasia. Clinicians need to 
explain the procedure repeatedly, speak-
ing more slowly/louder and answering all 
questions. Simple measures that can im-
prove understanding include disclosure 
of information using simple and direct 
language; giving information in small 
units; using assessment methods that 
are less dependent on verbal expres-
sion; using a variety of novel formats 
(e.g., storybook, video) and procedures 
(e.g., use of health educators, quizzing 
subjects, multiple disclosure sessions) 
to improve understanding of the medical 
information[6].
In clinical practice, mental capacity is 
presumed, unless the patient shows very 
obvious signs of a mental or cognitive 
disorder. Forms of dementing illnesses 
affecting cognition can be suspected 
when patients reveal impaired fluency of 
language, are vague with dates and se-
quence of events, repeat phrases, or 
have a tendency to dwell distant 
events[15].
Patients with loss of interest, poor con-
centration, forgetfulness, negative out-
look with feelings of hopelessness, and 
diminished capacity for enjoyment can 
suffer depression which results in lesser 
cognitive capacity and, for patients with 
diminished but not permanently impaired 
cognitive capacity, participation in the 
decision taking process constitutes a 
heavy burden. Many patients with some 
degree of mental impairment are still ca-
pable of participating in medical deci-
sion-making and should be treated using 
their will. Asking the patient to rephrase 
the information received (e.g., plan and 
risks of the procedure) can help assess 
capacity; however, interviews, formal al-
gorithm and rating scales have been de-
vised to assess capacity for cognitive as-
sessment[16], and the use of a structured 
approach to assess decision-making ca-
pacities can be very helpful.
Cognitive assessment
Cognitive assessment may involve ex-
amination of higher cortical functions, 
particularly memory, attention, orienta-
tion, language, executive function (plan-
ning activities), and praxis (sequencing of 
activities). An ideal clinical cognitive as-
sessment tool should be brief and relia-
ble, and facilitate documentation of the 
four capacity abilities: understanding the 
information regarding the proposed treat-
ment and its risks and benefits, appreci-
ating treatment methods and their con-
sequences, reasoning about the different 
treatment options and communicating a 
choice[4,17]. Table I describes these four 
criteria and how they can be assessed[2].
Understanding
The patient needs to recall conversations 
about treatment, to make the link be-
tween causal relationships, and to pro-
cess probabilities for outcomes. He/she 
must understand the known risks and 
benefits of the treatment and its alterna-
tive. Problems with memory, attention 
span, and intelligence (capability to un-
derstand) can affect the understanding.
Appreciation
The patient should be able to appreciate 
his/her clinical situation, his/her illness, 
treatment options, and likely outcomes 
as things that will affect him/her directly. 
A lack of appreciation usually stems from 
a denial based on lack of capability to un-
derstand, or emotion, or a delusion that 
the patient is not affected by this situa-
tion the same way and will have a differ-
ent outcome.
Rationalization or reasoning
The patient needs to be able to weigh the 
risks and benefits of the treatment op-
tions presented in order to come to a 
conclusion in keeping with his/her goals 
and best interests, as defined by his/her 
personal set of values. The patient must 
demonstrate the ability to both ask and 
answer appropriate questions relating to 
the decision. Rationalization/reasoning 
often is affected in psychosis, depres-
sion, anxiety, phobias, delirium, and de-
mentia.
Communication/expressing 
a choice
The patient needs to be able to express a 
treatment choice, and this decision 
needs to be stable enough for the treat-
ment to be implemented. Changing the 
decision in itself would not bring a pa-
tient’s capacity into question, so long as 
the patient is able to explain the rationale 
behind. Frequent changes in the deci-
sion-making, however, could suggest un-
derlying psychiatric disorders or extreme 
indecision, which could bring capacity in-
to question.
The use of structured approaches to as-
sess these abilities can be very helpful for 
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termined cutoff separating capacity and 
incapacity and appears difficult to use 
and time-consuming[11].
Aid to Capacity Evaluation 
Sessums et al. searched for a valid, relia-
ble, and clinically useful tool for assess-
ing and documenting patient’s capacity 
and concluded that the Aid to Capacity 
Evaluation (ACE) instrument is the best 
evaluation tool, because it is the only in-
strument evaluated against a gold stand-
ard with consistent correlation with vali-
dation studies and robust test character-
istics[4]. The purpose of the Aid to Capac-
ity Evaluation (ACE) is to help clinicians 
systematically estimate capacity when a 
patient needs to take a medical deci-
sion[20]. The ACE is based on the actual 
decision the patient is facing, uses the 
patient’s medical situation and diagnosis 
or treatment decision.
The ACE is a structured interview that as-
sess understanding of the problem, treat-
ment proposed, treatment alternatives, 
the option to refuse treatment, possible 
the clinician, and various interviews and 
rating scales have been devised to assess 
capacity, many of which focus on these 
four (or similar) dimensions (table I)[4,12,18].
Clinical tools to assess 
capacity
Over the year, several clinical tools have 
been developed to assess decisional ca-
pacity to consent to medical treat-
ment[4,13,18]. There has been ongoing de-
bate regarding competence assessment, 
and to-date, the quest for a simple neu-
ropsychological instrument to screen pa-
tients for impaired capacity has not yield-
ed consistent findings. 
MacArthur Competence 
Assessment Tool for Treatment
In a review describing structured assess-
ments of capacity in adult patients, Dunn 
et al. identified 23 instruments, 15 of 
which could be suitable for assessing ca-
pacity to consent to medical treatment[18]. 
The authors demonstrated that each in-
strument has limitations, and as a gener-
al recommendation they suggested, as 
best choice, the MacArthur Competence 
Assessment Tools for Treatment (Mac-
CAT-T), given the comprehensiveness 
and the supporting psychometric data[18]. 
The MacCAT-T may provide reliable and 
valid estimates of patients capacities[19]. 
The MacCAT-T is a semi-structured inter-
view that takes approximately 20 min for 
clinicians with experience with the for-
mat[12].
The MacCAT-T is used to assess the four 
major abilities related to competence to 
consent to treatment, and assists in the 
detection of inadequacies in any of the 
four areas (table I)[19]. The MacCAT-T has 
been validated in a broad population. It is 
probably one of the most clinically useful 
tools currently available, and is among 
the few instruments for which extensive 
training materials are available. 
It is designed not as a stand-alone tool 
for capacity, and is supposed to be used 
in conjunction with clinical assessment. 
Unfortunately, the MacCAT-T tool does 
not give a global rating, lacks of a prede-
Table I Relevant criteria for decision-making capacity during patient assessment 
(modified from Grisso and Appelbaum)19
Component Patient’s role Physician’s approach Sample questions Impaired in
Understanding
Recall information, link 
causal relationships, 
process general 
probabilities
Encourage patient to 
paraphrase his/her view of 
the information
Can you tell me: how you view 
the current situation?
The possible benefits/risks 
of the treatment?
Problems with 
memory, attention 
span, intelligence
Appreciation 
Identify illness, 
treatment options, 
and consequences of 
treatment options
Ask patient to describe 
the disease, the proposed 
treatment, and likely 
outcomes 
What do you believe is wrong 
with your health?
What treatment do you 
think would help?
What other options do 
you have?
Delusional disorder 
or pathologic 
levels of distortion 
or denial
Rationalization
Weigh risks and 
benefits to come to a 
conclusion in keeping 
with patient’s goals
Ask the patient to compare 
risk vs benefits of the 
proposed treatment and 
alternatives
What made you choose 
option “A”?
Why do you think opinion “A” 
is better than option “B”?
Depression, 
psychotic thought 
disorder, anxiety, 
phobia, delirium, 
dementia
Communication
Express a treatment 
choice 
Ask patient which treatment, 
option he/she prefers
Have you decided whether 
to get “A” or “B” treatment?
Psychiatric disorders, 
pathological 
indecision
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consequences of the decision, and the 
effects on the final decision of an under-
lying mental disorder (major depression 
and psychosis). Based on the answers, 
the examiner gives an overall impression 
of “definitely capable”, “probably capa-
ble”, “probably incapable”, or “definitely 
incapable”[20]. The Aid to Capacity Evalu-
ation can be performed in less than 
30 minutes[4], is available for free online 
(http://www.jcb.utoronto.ca/tools/ace_
download.shtml, accessed July 2017) 
and includes training material and a man-
ual that provides objective criteria for 
scoring responses.
Mini Mental State Examination 
The Mini Mental State Examination 
(MMSE) tool is a brief bedside screening 
test of patient’s cognitive function, and 
has been found to correlate with clinical 
judgments of incapacity[3,21]. The MMSE 
is designed to be administered by any 
clinician, including physicians or nurses, 
and may be administered by trained lay 
interviewers.
The MMSE is a well validated, 30 points 
cognitive test that comprises 11 items, 
does not require formal training, and 
takes less than ten minutes to complete. 
The scores range from 0 to 30, with lower 
scores indicating decreasing cognitive 
function: specifically, a MMSE score of 0 
to 17 increases the likelihood of lack of 
capacity, a score of 18 to 23 indicates 
mild cognitive impairment, while a score 
of 24 to 30 significantly reduces the likeli-
hood of incapacity[20]. The MMSE, cor-
rected for the level of education, can be 
used as a very easy screen for identifying 
patients at the high and low ends of the 
range of capacity, especially among el-
derly persons with some degree of cog-
nitive impairment[10,22].
The MMSE quantitatively assesses the 
severity of cognitive impairment, and 
documents cognitive changes occurring 
over time[23]. The MMSE test does not 
address any specific aspects of in-
formed consent, such as understanding 
or choice; it was not developed for as-
sessing decision-making capacity, how-
ever it has been compared with expert 
evaluation for assessment of capacity 
and the test performs reasonably well, 
particularly with high and low scores[10]. 
The MMSE can be used as a very simple 
screening test, and for any patient with 
MMSE below 24 a combination of the 
MMSE and a brief question based inter-
view (such as the ACE) may be sufficient 
to determine decision-making capaci-
ty[4,24]. Copyright protection is now en-
forced, and the Mini Mental State Exam-
ination must be purchased from the pub-
lishers.
The Administration and Scoring Manual 
contains detailed information about ad-
ministration, scoring, and choosing which 
version of the MMSE to use (http://www.
parinc.com, free training on-line, ac-
cessed July 2017). 
3. CONCLUSIONS
Any physician should be familiar with how to assess capacity, and the selection of the right assessing instrument depends on 
the context in which it is to be used. Decisions about capacity by the physicians are often made in the absence of any docu-
mented assessment of cognition or other objective evidence that could support their decision, in the event of dispute. Determi-
nation of capacity is a function for which most physicians have little experience and training. Although the clinician does not 
need to make “definitive” capacity determinations, he/she needs to discriminate between patients able to consent to medical 
treatment and patients who require further evaluation or remediation. 
We think that MMSE can be the easiest choice to use in the daily practice to assess capacity to consent to medical treatment 
for elderly patients[25].
The MMSE is simple to use, is objective because it is based on fixed scores, it allows the evaluation of patients who are unable 
to complete more detailed cognitive tests, its administration takes only few minutes (<10 min), it is easly replicable, and has 
been translated in several languages. Most importantly, it does not require a specific training of personnel and provides a score 
easily exploitable by the physician.
In cases of low MMSE score, suggesting likelihood of lack of capacity[20], the informed consent to be valid must be provided by 
a legal representative. Individuals who are likely to loose capacity may assign a surrogate who will take on an increasingly acti-
ve role in decision making, as the subject declines. In presence of advance directives indicating a treatment choice, the person 
designed by the patient can make a decision on his/her behalf. In absence of advance directives, a substitute is designed ac-
cording to local law and jurisdiction[25]. 
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DISCUSSIONE
Il consenso informato nei pazienti anziani presenta molte sfide etiche e legali. L’invecchiamento dell’individuo comporta il ri-
schio di decadimento cognitivo e quindi di una capacità decisionale più o meno compromessa. L’invecchiamento cognitivo è 
difficile da definire e da misurare e impossibile da prevedere; tuttavia, una ridotta comprensione delle informazioni in pazienti 
con età avanzata è frequente e ampiamente riportata in letteratura. Non ci sono linee guida ufficiali delle società scientifiche per 
la valutazione della capacità di consenso al trattamento. Durante la visita, il paziente anziano si trova in un ambiente non fami-
liare e molto spesso la sua malattia può portare a confusione e agitazione. 
CONCLUSIONI
Tutti i medici dovrebbero avere le competenze per individuare lo strumento di valutazione più adatto allo specifico contesto in 
cui deve essere utilizzato. L’MMSE potrebbe essere considerata la scelta più semplice da utilizzare nella pratica quotidiana per 
valutare la capacità di consentire il trattamento medico per i pazienti anziani. L’MMSE è semplice da usare, è oggettivo perché 
basato su punteggi fissi, consente la valutazione di pazienti che non sono in grado di completare test cognitivi più dettagliati, la 
sua somministrazione richiede solo pochi minuti (<10 minuti), è facilmente replicabile ed è stato tradotto in diverse lingue. So-
prattutto, non richiede una formazione specifica e fornisce un punteggio facilmente fruibile dal medico.
SIGNIFICATO CLINICO
Ogni paziente adulto è considerato legalmente competente; tuttavia, nella pratica clinica ci si trova sovente a dover valutare la 
capacità decisionale dei soggetti. In caso di dubbio, la capacità del paziente di fornire il consenso medico dovrebbe essere va-
lutata utilizzando strumenti specifici appropriati, funzione per la quale la maggior parte dei medici ha poca esperienza e forma-
zione. Sebbene il clinico non debba effettuare determinazioni di capacità “definitive”, deve avere le competenze per discrimina-
re tra i soggetti in grado di prendere delle decisioni mediche e quelli che richiedono la messa in atto di ulteriori procedure secon-
do le leggi e la giurisdizione del paese coinvolto.
INTRODUZIONE
Il consenso informato è il processo attra-
verso il quale i pazienti accettano una 
procedura medica o un trattamento ri-
guardante la loro salute. Il processo in-
clude una discussione approfondita tra il 
clinico e il paziente e copre tutti gli aspet-
ti rilevanti del trattamento proposto. Il 
consenso è valido se è dato volontaria-
mente da un paziente adeguatamente in-
formato e in grado di comprendere. Nella 
popolazione geriatrica la valutazione del-
la competenza/capacità può essere un 
compito complesso e il medico deve po-
ter capire se il paziente è in grado di 
prendere una decisione medica e dare il 
proprio consenso.
MATERIALI E METODI
I database PubMed (Medline), Google 
Scholar e Cochrane sono stati utilizzati 
per cercare articoli originali che descrivo-
no i metodi di screening per la valutazio-
ne del deterioramento cognitivo nei pa-
zienti anziani. Anche le revisioni della let-
teratura esistenti sull’argomento sono 
state considerate come informazioni ag-
giuntive. In questa revisione della lettera-
tura, sono stati considerati i metodi di 
screening più frequentemente utilizzati 
per valutare la capacità decisionale del 
paziente: MacArthur Competence As-
sessment Tool for Treatment (MacCAT-T), 
Aid to Capacity Evaluation (ACE) e Mini 
Mental State Examination (MMSE).
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